强骨宝对糖尿病性骨质疏松症患者骨密度及生化指标的影响  

Effect of Qianggubao on Bone Density and Biochemical Quota of Diabetic Osteoporosis(DOP)Patients

作　　者：苏友新[1] 郑良朴[1] 钱松涛[1] 董忠[2] 郭进建[3] 张安桢[1] 

机构地区：[1]福建中医学院,福州350003 [2]福建省第二人民医院 [3]福建省人民医院

出　　处：《浙江中医学院学报》2002年第4期15-17,共3页Journal of Zhejiang College of Traditional Chinese Medicine

基　　金：福建省自然科学基金资助(编号 :C9810036)

摘　　要：对40例糖尿病性骨质疏松症(DOP)患者进行强骨宝颗粒剂用药前后腰椎骨密度(BMD)、空腹血糖(FBG)、血清果糖胺(FSM)及有关骨代谢的血尿生化指标变化的检测 ,结果显示强骨宝用药20W后 ,患者BMD提高了1 849 % ,FBG、FSM显著下降(P<0 05 ,P<0 01) ,BGP、S -Mg非常显著升高(P<0 01) ,尿钙、尿磷、尿羟脯氨酸排泄量显著减少(P<0 05)。揭示强骨宝可以提高DOP患者的BMD ,并且可能是通过降血糖、促进骨形成。Test the bone density of lumbar vertebreae(BMD),fasting blood glucose(FBG),serum fructose amine(FSM)and the hematuria biochemical quota about bone metabolism for 40 cases of DOP patients before and after taking Qianggubao granule.The results showed that after taking the medicine for 20w,patiens' BMD rose by 1 849%,FBG and FSM marked decreasedhy(P<0 01,P<0 01),the excretion of urine C,P and Hyp obviously decreased(P<0 05). It indicated that Qianggubao could increase DOP patients BMD which might be functioned by lowering blood gulcose,promoting bone formation and inhibiting bone absorption.

关 键 词：糖尿病性骨质疏松症 强骨宝 骨密度 血尿生化指标 DOP 空腹血糖 血清果糖胺 

分 类 号：R274.91[医药卫生—中西医结合] R285[医药卫生—中医骨伤科学]